← Back to Search

UniVenture Program for Reducing Heavy Drinking and Substance Misuse

N/A
Recruiting
Led By Marvin Krank
Research Sponsored by Sherry Stewart
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18- 25 years
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial is studying a program to reduce heavy drinking and other substance misuse among first and second year undergraduates at 5 Canadian universities. The program will be delivered in person and online, and compared to usual campus services.

Who is the study for?
The UniVenture Program is for 1st and 2nd year undergraduates aged 18-25 at select Canadian universities who've used substances in the past 3 months and score high on certain personality traits linked to substance misuse. Students must be willing to participate.Check my eligibility
What is being tested?
This trial tests a wellness program aimed at reducing heavy drinking and substance misuse by targeting specific personality traits. It compares face-to-face and technology-assisted formats against standard university services.See study design
What are the potential side effects?
Since this is a behavioral intervention focusing on wellness, traditional medical side effects are not expected. However, participants may experience emotional or psychological discomfort when discussing personal issues related to substance use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 25 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in alcohol-related harms in undergraduates
Changes in cannabis-related harms in undergraduates
Changes in the student wellbeing in undergraduates
Secondary outcome measures
Changes in score of hazardous drinkers in undergraduates
Changes in scores on the undergraduate self-regulated learning (SRL) behaviour measure and Self-efficacy beliefs for undergraduates' success measures
Changes in scores on the undergraduates' Academic challenges measure
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: UniVenture- face-to-face (in-person format)Experimental Treatment4 Interventions
Personality-matched wellness program condition in face-to-face format (i.e., high AS student receives face-to-face AS program; high HOP student receives face-to-face HOP workshop: high SS student receives face-to-face SS workshop; high IMP student receives face-to-face IMP workshop)
Group II: UniVenture- online (distance-delivery format)Active Control4 Interventions
Personality-matched wellness program condition in distance-delivery format (i.e., high AS student receives online (distance-delivered) AS workshop; high HOP student receives online (distance-delivered) HOP workshop: high SS student receives online (distance-delivered) SS workshop; high IMP student receives online (distance-delivered) IMP workshop
Group III: UniVenture- service as usual (control)Placebo Group1 Intervention
Services-as-usual offered by the respective university

Find a Location

Who is running the clinical trial?

Strategy for Patient Orientated ResearchUNKNOWN
University of VictoriaOTHER
57 Previous Clinical Trials
10,641 Total Patients Enrolled
Canadian Research Initiative in Substance MisuseOTHER

Media Library

UniVenture Anxiety Sensitivity manual Clinical Trial Eligibility Overview. Trial Name: NCT05383989 — N/A
Impulsivity Research Study Groups: UniVenture- face-to-face (in-person format), UniVenture- online (distance-delivery format), UniVenture- service as usual (control)
Impulsivity Clinical Trial 2023: UniVenture Anxiety Sensitivity manual Highlights & Side Effects. Trial Name: NCT05383989 — N/A
UniVenture Anxiety Sensitivity manual 2023 Treatment Timeline for Medical Study. Trial Name: NCT05383989 — N/A
~273 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top